Ferric Citrate 1 gram Oral Tablet + Standard of care phosphate-lowering therapy
ApprovedCompleted 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Hyperphosphatemia
Conditions
Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency
Trial Timeline
Jun 29, 2021 → Sep 15, 2022
NCT ID
NCT04922645About Ferric Citrate 1 gram Oral Tablet + Standard of care phosphate-lowering therapy
Ferric Citrate 1 gram Oral Tablet + Standard of care phosphate-lowering therapy is a approved stage product being developed by Akebia Therapeutics for Hyperphosphatemia. The current trial status is completed. This product is registered under clinical trial identifier NCT04922645. Target conditions include Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency.
Hype Score Breakdown
Clinical
30
Activity
20
Company
2
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04922645 | Approved | Completed |
Competing Products
20 competing products in Hyperphosphatemia